Prof. Ugur Sahin, M.D.

CEO and Co-Founder at BioNTech

Board

Since N/A

Age

58 years

Education

Holds a medical degree (M.D.) from Johannes Gutenberg University in Mainz, Germany.

Tenure

Co-founded BioNTech and currently serves as its CEO, playing a pivotal role in shaping the company's strategy, innovation, and advancement of novel therapies.

Also at BioNTech

Jens Holstein

Chief Financial Officer (CFO)

Ryan Richardson

Chief Strategy Officer (CSO)

Sean Marett

Chief Business Officer (CBO) and Chief Commercial Officer (CCO)

About

As the CEO and Co-Founder of BioNTech, he has been instrumental in transforming the company into a global leader in immunotherapy and vaccine development, driving both research innovation and strategic growth.

His leadership has been marked by significant contributions to advancing oncology pipelines, including the development of mRNA cancer vaccines, antibody-drug conjugates, and CAR-T therapies, as well as the successful commercialization of a COVID-19 vaccine.

In addition to his role in leading breakthrough scientific initiatives, he has championed the integration of artificial intelligence into the discovery process, emphasizing personalized medicine and the development of novel therapeutic solutions.

Although detailed information about his early personal background is limited, his professional journey and ongoing impact at BioNTech underscore his commitment to advancing global healthcare through innovative biotechnology.

$BNTX Performance Under Prof. Ugur Sahin, M.D.

External Roles

Organization	Role	Date Range	Details
Johannes Gutenberg University, Mainz	Full Professor (W3) in Translational Oncology & Immunology	N/A	Supervised more than 50 Ph.D. students
Helmholtz Institute for Translational Oncology (HI-TRON), Mainz	Chair of the Scientific Management Board	N/A	N/A